Skip to main content

About us

We’re innovating technology to eliminate the bottlenecks in bioprocessing.

Culture is revolutionizing upstream bioprocess development with cloud-native software that makes data accessible, contextualized, and actionable—unlocking the full potential of AI and machine learning in bioprocessing.

Chris-Williams

Chris Williams

CEO, Culture Biosciences

Where we’ve been, 
and where we’re going.

2018
CultureBiosciences_About_Timeline_1-Console

Console

With the goal of making bioprocess development as easy as possible, we designed ConsoleTM to be an intuitive way for scientists to design and analyze their experiments from the web.

CultureBio-Product-252-Edit_full_Mammalian-250mL-Bioreactor

250mL bioreactor

Our 250 mL bioreactor was designed for fed-batch microbial and fermentation processes. We manufactured and scaled out these reactors to accommodate a growing customer base of therapeutics and synthetic biology customers.

2022
CultureBio-Product-165-Edit_full_5L-Microbial

5L bioreactor

After listening to our customers, we heard that their biggest need was material for process development. We launched our 5L reactors to enable large-batch material generation.

2025
20250210-Culture_Biosciences-5766-RT2

Stratyx™ 250

Building on the success of our 250mL and 5L bioreactors, Stratyx 250™ represents the next evolution in cloud-integrated bioprocessing, right in the hands of our users.

Leadership

Chris Williams

Chris Williams

Chief Executive Officer

Scott Greenstone

Scott Greenstone

Senior Vice President, Finance

Lauren Kellogg

Lauren Kellogg

Vice President of Strategy & Corporate Development

Barbara Weaver

Barbara Weaver

Director, Human Resources

Randy Roushall

Randy Roushall

Senior Director Engineering

Board of Directors

Chris Williams

Chris Williams

Chief Executive Officer

Andrew Lee

Andrew Lee

Principal at Northpond Ventures

Shivani Oberoi

Shivani Oberoi

Investment Principal at Synthesis Capital

Dan Phillips

Dan Phillips

Partner of Cultivian Sandbox and Sandbox Sustainability Ventures at Sandbox Industries

Mike Stapleton

Mike Stapleton

Chief Business Officer, QbDVision

Nick Futrell

Nick Futrell (Observer)

Senior Associate at Northpond Ventures

Costa Yiannoulis

Costa Yiannoulis (Observer)

Co-founder and Managing Partner of Synthesis Capital

Advisory Board

Joydeep Ganguly

Joydeep Ganguly

Chief Operations & Quality Officer, Agilent Technologies

Bob Todd

Bob Todd, PhD

Digital Process Design Pioneer and former Senior Vice President, Technology and Innovation at KBI Pharma

Phil Vanek

Phil Vanek, PhD

Chief Technology Officer at Gamma Biosciences

Eliana Clark

Eliana Clark PhD

Executive Vice President and Chief Technical Officer at Intellia Therapeutics, Inc.

Investors

northpond-ventures
synthesis-capital
cultivian-sandbox
section-32
e14
verily

Grow with
Culture